Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Atreca, Inc.
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
December 26, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
IMNM
Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives
November 14, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
September 21, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring
August 10, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting
June 05, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments
May 10, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting
April 26, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 13, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
March 29, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023
March 23, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca to Participate at Cowen’s 43rd Annual Health Care Conference
March 01, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target
February 06, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Appoints Philippe Bishop, MD as Chief Medical Officer
January 09, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Reports Third Quarter 2022 Financial Results and Provides Pipeline Update
November 10, 2022
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca to Present at Upcoming Investor Conferences
November 07, 2022
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 05, 2022
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.